{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:58:48Z","timestamp":1793386728309,"version":"4.5.0"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,7]]},"DOI":"10.1093\/eurheartj\/ehaa1096","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T06:32:17Z","timestamp":1608791537000},"page":"985-1003","source":"Crossref","is-referenced-by-count":24,"title":["The year in cardiovascular medicine 2020: interventional cardiology"],"prefix":"10.1093","volume":"42","author":[{"given":"Fernando","family":"Alfonso","sequence":"first","affiliation":[{"name":"Cardiology Department, Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria IIS-IP, Universidad Aut\u00f3noma de Madrid, CIBERCV , C\/Diego de Le\u00f3n 62, Madrid 28006, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3827-945X","authenticated-orcid":false,"given":"Nieves","family":"Gonzalo","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Clinico San Carlos, IdISSC, Universidad Complutense de Madrid . C\/ Mart\u00edn Lagos s\/n 28042 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3676-0277","authenticated-orcid":false,"given":"Fernando","family":"Rivero","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria IIS-IP, Universidad Aut\u00f3noma de Madrid, CIBERCV , C\/Diego de Le\u00f3n 62, Madrid 28006, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-0112","authenticated-orcid":false,"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Clinico San Carlos, IdISSC, Universidad Complutense de Madrid . C\/ Mart\u00edn Lagos s\/n 28042 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2022102516094805700_ehaa1096-B1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jamacardio.2020.3538","article-title":"Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study","volume":"5","author":"Lombardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022102516094805700_ehaa1096-B2","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehaa408","article-title":"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","volume":"41","author":"Shi","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/eurheartj\/ehaa396","article-title":"Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement","volume":"41","author":"Peretto","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B4","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","article-title":"Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study","volume":"41","author":"Basso","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B5","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","volume":"41","author":"Inciardi","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B6","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/eurheartj\/ehaa400","article-title":"Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection","volume":"41","author":"Fernandez Gasso","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B7","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/eurheartj\/ehaa306","article-title":"Typical takotsubo syndrome triggered by SARS-CoV-2 infection","volume":"41","author":"Meyer","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B8","article-title":"Severe coronary spasm in a COVID-19 patient","author":"Rivero","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B9","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMc2009020","article-title":"ST-segment elevation in patients with COVID-19\u2014a case series","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102516094805700_ehaa1096-B10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19","volume":"76","author":"Nadkarni","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2020.07.022","article-title":"High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction","volume":"76","author":"Choudry","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B12","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/eurheartj\/ehaa507","article-title":"Acute coronary syndromes in developing countries during the COVID-19 pandemic","volume":"41","author":"Said","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ehjqcco\/qcaa046","article-title":"Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology","volume":"6","author":"Pessoa-Amorim","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2022102516094805700_ehaa1096-B14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2020.04.039","article-title":"Management of acute myocardial infarction during the COVID-19 pandemic: a position statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP","volume":"76","author":"Mahmud","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B15","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/eurheartj\/ehaa508","article-title":"COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests","volume":"41","author":"Baldi","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B16","first-page":"82","article-title":"Impact of the COVID-19 pandemic on interventional cardiology activity in Spain","volume":"2","author":"Rodriguez-Leor","year":"2020","journal-title":"REC Interv Cardiol"},{"key":"2022102516094805700_ehaa1096-B17","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jacc.2020.09.546","article-title":"Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI","volume":"76","author":"De Luca","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B18","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehaa409","article-title":"Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era","volume":"41","author":"De Rosa","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(20)31356-8","article-title":"COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England","volume":"396","author":"Mafham","year":"2020","journal-title":"Lancet"},{"key":"2022102516094805700_ehaa1096-B20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/eurheartj\/ehaa381","article-title":"EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic","volume":"41","author":"Chieffo","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102516094805700_ehaa1096-B22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102516094805700_ehaa1096-B23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102516094805700_ehaa1096-B24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.120.048194","article-title":"Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials","volume":"142","author":"Bangalore","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/eurheartj\/ehx486","article-title":"The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives","volume":"39","author":"Konigstein","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B27","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","article-title":"EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders Internati","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B28","article-title":"Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of MINOCA in women","author":"Reynolds","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B29","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa624","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","author":"Collet","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B30","author":"Brugaletta","year":"2020"},{"key":"2022102516094805700_ehaa1096-B31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/eurheartj\/ehy651","article-title":"Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial","volume":"40","author":"Lemkes","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(20)30930-2","article-title":"Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data","volume":"396","author":"Kaura","year":"2020","journal-title":"Lancet"},{"key":"2022102516094805700_ehaa1096-B33","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jcin.2020.04.055","article-title":"Multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease: meta-analysis of randomized trials","volume":"13","author":"Atti","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B34","doi-asserted-by":"crossref","first-page":"e016575","DOI":"10.1161\/JAHA.120.016575","article-title":"Optimal revascularization strategy in non-ST-segment-elevation myocardial infarction with multivessel coronary artery disease: culprit-only versus one-stage versus multistage revascularization","volume":"9","author":"Kim","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022102516094805700_ehaa1096-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2020.3670","article-title":"Coronary angiography after cardiac arrest without ST segment elevation: one-year outcomes of the COACT randomized clinical trial","volume":"5","author":"Lemkes","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022102516094805700_ehaa1096-B36","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/eurheartj\/ehz753","article-title":"Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study","volume":"41","author":"Bougouin","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B37","article-title":"Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and\/or cardiogenic shock: Insights from a network meta-analysis of randomized trials","author":"Kuno","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B38","article-title":"Short term outcomes of Impella in cardiogenic shock: a review and meta-analysis of observational studies","author":"Siannaccone","year":"2020","journal-title":"Int J Cardiol"},{"key":"2022102516094805700_ehaa1096-B39","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.carrev.2020.05.042","article-title":"Impella versus extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock","volume":"21","author":"Lemor","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"2022102516094805700_ehaa1096-B40","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.120.048792","article-title":"Left ventricular unloading is associated with lower mortality in cardiogenic shock patients treated with veno-arterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study","volume":"142","author":"Schrage","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B41","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial","volume":"394","author":"Thuijs","year":"2019","journal-title":"Lancet"},{"key":"2022102516094805700_ehaa1096-B42","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCULATIONAHA.120.046039","article-title":"Ten-year outcomes after drug-eluting stents versus coronary artery bypass grafting for left main coronary disease: extended follow-up of the PRECOMBAT trial","volume":"141","author":"Park","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B43","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","article-title":"Five-year outcomes after PCI or CABG for left main coronary disease","volume":"381","author":"Stone","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102516094805700_ehaa1096-B44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial","volume":"395","author":"Holm","year":"2020","journal-title":"Lancet"},{"key":"2022102516094805700_ehaa1096-B45","article-title":"Percutaneous vs. surgical revascularization for patients with unprotected left main stenosis: a meta-analysis of 5-year follow-up randomized controlled trials","author":"D\u2019Ascenzo","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2022102516094805700_ehaa1096-B46","article-title":"Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: a meta-analysis","author":"Gallo","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022102516094805700_ehaa1096-B47","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1093\/eurheartj\/ehaa135","article-title":"Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials","volume":"41","author":"Ahmad","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B48","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2020.08.016","article-title":"Implications of alternative definitions of peri-procedural myocardial infarction after coronary revascularization","volume":"76","author":"Gregson","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcin.2019.09.019","article-title":"Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL trial","volume":"13","author":"Giustino","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B50","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ejhf.1681","article-title":"Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial","volume":"22","author":"Thuijs","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022102516094805700_ehaa1096-B51","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.jcin.2020.07.017","article-title":"Long-term prognostic impact of restenosis of the unprotected left main coronary artery requiring repeat revascularization","volume":"13","author":"Wiebe","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B52","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jacc.2020.07.047","article-title":"Revascularization in patients with left main coronary artery disease and left ventricular dysfunction","volume":"76","author":"Park","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jacc.2020.06.052","article-title":"Long-term survival after surgical or percutaneous revascularization in patients with diabetes and multivessel coronary disease","volume":"76","author":"Tam","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B54","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/eurheartj\/ehaa543","article-title":"Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial","volume":"41","author":"Zhang","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B55","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jcin.2020.03.054","article-title":"Clinical outcomes following coronary bifurcation PCI techniques: a systematic review and network meta-analysis comprising 5,711 patients","volume":"13","author":"Gioia","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B56","doi-asserted-by":"crossref","first-page":"e008325","DOI":"10.1161\/CIRCINTERVENTIONS.119.008325","article-title":"Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study","volume":"13","author":"Gaido","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4244\/EIJ-D-19-00851","article-title":"Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial","volume":"16","author":"Kini","year":"2020","journal-title":"EuroIntervention"},{"key":"2022102516094805700_ehaa1096-B58","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jcin.2019.10.062","article-title":"Percutaneous treatment and outcomes of small coronary vessels: a SCAAR report","volume":"13","author":"Silverio","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B59","doi-asserted-by":"crossref","first-page":"e009189","DOI":"10.1161\/CIRCINTERVENTIONS.120.009189","article-title":"Comparison of ultrathin, bioresorbable-polymer sirolimus-eluting stents and thin, durable-polymer everolimus-eluting stents in calcified or small vessel lesions","volume":"13","author":"Dan","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B60","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)","volume":"41","author":"Giacoppo","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B61","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B62","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.4244\/EIJ-D-19-00631","article-title":"Ischaemic burden and changes in absolute myocardial perfusion after chronic total occlusion percutaneous coronary intervention","volume":"16","author":"Schumacher","year":"2020","journal-title":"EuroIntervention"},{"key":"2022102516094805700_ehaa1096-B63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcin.2019.10.028","article-title":"Retrograde chronic total occlusion percutaneous coronary intervention via saphenous vein graft","volume":"13","author":"Xenogiannis","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B64","doi-asserted-by":"crossref","first-page":"e1615","DOI":"10.4244\/EIJ-D-19-00352","article-title":"CASTLE score versus J-CTO score for the prediction of technical success in chronic total occlusion percutaneous revascularisation","volume":"15","author":"Kalogeropoulos","year":"2020","journal-title":"EuroIntervention"},{"key":"2022102516094805700_ehaa1096-B65","doi-asserted-by":"crossref","first-page":"e1624","DOI":"10.4244\/EIJ-D-18-00993","article-title":"Successful guidewire crossing via collateral channel at retrograde percutaneous coronary intervention for chronic total occlusion: the J-Channel score","volume":"15","author":"Nagamatsu","year":"2020","journal-title":"EuroIntervention"},{"key":"2022102516094805700_ehaa1096-B66","doi-asserted-by":"crossref","first-page":"e009049","DOI":"10.1161\/CIRCINTERVENTIONS.120.009049","article-title":"Clinical characteristics and outcomes from percutaneous coronary intervention of last remaining coronary artery: an analysis from the British Cardiovascular Intervention Society Database","volume":"13","author":"Shoaib","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jacc.2020.05.026","article-title":"10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents","volume":"76","author":"Kufner","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B68","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.119.040241","article-title":"Randomized comparison of the polymer-free biolimus-coated biofreedom stent with the ultrathin strut biodegradable polymer sirolimus-eluting orsiro stent in an all-comers population treated with percutaneous coronary intervention: the SORT OUT IX trial","volume":"141","author":"Jensen","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B69","article-title":"Durable polymer versus biodegradable polymer drug-eluting stents after percutaneous coronary intervention in patients with acute coronary syndrome: the HOST-REDUCE-POLYTECH-ACS trial","author":"Kim","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B70","year":"2020"},{"key":"2022102516094805700_ehaa1096-B71","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B72","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2019.11.065","article-title":"Survival after coronary revascularization with paclitaxel-coated balloons","volume":"75","author":"Scheller","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B73","doi-asserted-by":"crossref","first-page":"e016224","DOI":"10.1161\/JAHA.120.016224","article-title":"Clinical and angiographic outcomes with drug-coated balloons for de novo coronary lesions: a meta-analysis of randomized clinical trials","volume":"9","author":"Elgendy","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022102516094805700_ehaa1096-B74","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B75","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jcin.2020.02.019","article-title":"Ultrathin bioresorbable-polymer sirolimus-eluting stents versus thin durable-polymer everolimus-eluting stents for coronary revascularization: 3-year outcomes from the randomized BIOFLOW V trial","volume":"13","author":"Kandzari","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B76","doi-asserted-by":"crossref","first-page":"e008737","DOI":"10.1161\/CIRCINTERVENTIONS.119.008737","article-title":"Final 3-year outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent: insights from the DESSOLVE III All-Comers Randomized Trial","volume":"13","author":"Takahashi","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B77","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.jacc.2020.09.603","article-title":"Intravascular lithotripsy for treatment of severely calcified coronary artery disease: the Disrupt CAD III study","volume":"76","author":"Hill","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B78","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.jcin.2020.04.021","article-title":"Titanium-nitride-oxide-coated versus everolimus-eluting stents in acute coronary syndrome: the Randomized TIDES-ACS trial","volume":"13","author":"Tonino","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B79","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.119.043467","article-title":"Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI Randomized Clinical Trial","volume":"140","author":"Sabat\u00e9","year":"2019","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B80","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.4244\/EIJ-D-20-00198","article-title":"Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-Segment Elevation Myocardial Infarction: vascular healing outcomes from the MAGSTEMI trial","volume":"16","author":"Gomez-Lara","year":"2020","journal-title":"EuroIntervention"},{"key":"2022102516094805700_ehaa1096-B81","doi-asserted-by":"crossref","first-page":"e008657","DOI":"10.1161\/CIRCINTERVENTIONS.119.008657","article-title":"Mechanism of drug-eluting absorbable metal scaffold restenosis: a serial optical coherence tomography study","volume":"13","author":"Ueki","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcin.2019.09.033","article-title":"Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL Randomized trial","volume":"13","author":"Hong","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B83","article-title":"Three-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation"},{"key":"2022102516094805700_ehaa1096-B84","article-title":"Acute and one-year clinical outcomes of pre-stenting intravascular ultrasound: a patient-level meta-analysis of randomised clinical trials","author":"Hong","year":"2020","journal-title":"EuroIntervention"},{"key":"2022102516094805700_ehaa1096-B85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcin.2019.09.034","article-title":"Fractional flow reserve or optical coherence tomography to guide management of angiographically intermediate coronary stenosis: a single-center trial","volume":"13","author":"Burzotta","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","article-title":"Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study","volume":"41","author":"Prati","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B87","author":"Kedhi","year":"2020"},{"key":"2022102516094805700_ehaa1096-B88","doi-asserted-by":"crossref","first-page":"e008768","DOI":"10.1161\/CIRCINTERVENTIONS.119.008768","article-title":"Nonculprit lesion plaque morphology in patients with ST-segment-elevation myocardial infarction: results from the COMPLETE Trial Optical Coherence Tomography Substudys","volume":"13","author":"Pinilla-Echeverri","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B89","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.jacc.2020.09.547","article-title":"Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque","volume":"76","author":"Stone","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B90","doi-asserted-by":"crossref","first-page":"e009049","DOI":"10.1161\/CIRCINTERVENTIONS.119.008355","article-title":"Two-year outcomes after deferral of revascularization based on fractional flow reserve: the J-CONFIRM Registry","volume":"13","author":"Kuramitsu","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B91","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2019.10.060","article-title":"Utilization and outcomes of measuring fractional flow reserve in patients with stable ischemic heart disease","volume":"75","author":"Parikh","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B92","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jcin.2020.02.035","article-title":"Safety of revascularization deferral of left main stenosis based on instantaneous wave-free ratio evaluation","volume":"13","author":"Warisawa","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B93","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcin.2019.05.054","article-title":"Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary intervention: the DEFINE PCI study","volume":"12","author":"Jeremias","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102516094805700_ehaa1096-B94","author":"Patel","year":"2020"},{"key":"2022102516094805700_ehaa1096-B95","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1093\/eurheartj\/ehaa670","article-title":"Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS","volume":"41","author":"Baber","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B96","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO Randomized Clinical Trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"2022102516094805700_ehaa1096-B97","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1910021","article-title":"Polymer-based or polymer-free stents in patients at high bleeding risk","volume":"382","author":"Windecker","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102516094805700_ehaa1096-B98","author":"Mehran","year":"2020"},{"key":"2022102516094805700_ehaa1096-B99","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.120.046786","article-title":"Comparative efficacy and safety of oral P2Y12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials","volume":"142","author":"Navarese","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(20)31791-8","article-title":"Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial","volume":"396","author":"Kim","year":"2020","journal-title":"Lancet"},{"key":"2022102516094805700_ehaa1096-B101","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jacc.2020.08.053","article-title":"Timing of oral P2Y12 inhibitor administration in non-ST elevation acute coronary syndrome","volume":"76","author":"Tarantini","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102516094805700_ehaa1096-B102","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/CIRCULATIONAHA.120.051532","article-title":"COMPARE CRUSH: a randomized trial of prehospital crushed vs uncrushed prasugrel in STEMI","volume":"142","author":"Vlachojannis","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B103","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(20)30325-1","article-title":"Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial","volume":"395","author":"Gimbel","year":"2020","journal-title":"Lancet"},{"key":"2022102516094805700_ehaa1096-B104","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/CIRCULATIONAHA.120.050645","article-title":"Comparison between ticagrelor and clopidogrel in elderly patients with an acute coronary syndrome: insights from the SWEDEHEART Registry","volume":"142","author":"Szummer","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B105","author":"Hong","year":"2020"},{"key":"2022102516094805700_ehaa1096-B106","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCULATIONAHA.119.044598","article-title":"Rivaroxaban plus aspirin versus aspirin alone in patients with prior percutaneous coronary intervention (COMPASS-PCI)","volume":"141","author":"Bainey","year":"2020","journal-title":"Circulation"},{"key":"2022102516094805700_ehaa1096-B107","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(20)32236-4","article-title":"Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial","volume":"396","author":"Silvain","year":"2020","journal-title":"Lancet"},{"key":"2022102516094805700_ehaa1096-B108","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1093\/eurheartj\/ehaa475","article-title":"Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project","volume":"41","author":"Barbato","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102516094805700_ehaa1096-B109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/10\/985\/46628340\/ehaa1096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/10\/985\/46628340\/ehaa1096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T03:02:54Z","timestamp":1670554974000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/10\/985\/6100980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":109,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,1,15]]},"published-print":{"date-parts":[[2021,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1096","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,7]]},"published":{"date-parts":[[2021,1,15]]}}}